ACLARION, INC. Increase (Decrease) in Derivative Liabilities
ACLARION, INC. (ACON) reported Increase (Decrease) in Derivative Liabilities of -$18 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2026-08-06
- ACLARION, INC. increase (decrease) in derivative liabilities for the quarter ending 2026-06-30 was $0.00.
- ACLARION, INC. increase (decrease) in derivative liabilities for the quarter ending 2026-03-31 was -$18.00.
- ACLARION, INC. increase (decrease) in derivative liabilities for the quarter ending 2025-12-31 was -$39.00.
- ACLARION, INC. increase (decrease) in derivative liabilities for the quarter ending 2025-09-30 was -$1.00.
- ACLARION, INC. increase (decrease) in derivative liabilities for fiscal 2025 was -$11.81K.
- ACLARION, INC. increase (decrease) in derivative liabilities for fiscal 2024 was -$335.03K.
- ACLARION, INC. increase (decrease) in derivative liabilities for fiscal 2023 was -$646.32K.
- ACLARION, INC. increase (decrease) in derivative liabilities for fiscal 2022 was $0.00.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$18.00 10-Q · filed 2026-08-06 | -$57.00 derived: sum of 3 quarters · filed 2026-08-06 | -$58.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$18.00 10-Q · filed 2026-05-13 | -$57.00 derived: sum of 2 quarters · filed 2026-05-13 | -$58.00 derived: sum of 3 quarters · filed 2026-05-13 | -$103.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$39.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$40.00 derived: sum of 2 quarters · filed 2026-03-18 | -$85.00 derived: sum of 3 quarters · filed 2026-08-06 | -$11.81K 10-K · filed 2026-03-18 |
| 2025-09-30 | -$1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$46.00 derived: sum of 2 quarters · filed 2026-08-06 | -$11.77K 10-Q · filed 2025-11-12 | -$16.17K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$45.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$11.77K 10-Q · filed 2026-08-06 | -$16.17K derived: sum of 3 quarters · filed 2026-08-06 | -$23.76K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$11.72K 10-Q · filed 2026-05-13 | -$16.12K derived: sum of 2 quarters · filed 2026-05-13 | -$23.71K derived: sum of 3 quarters · filed 2026-05-13 | -$49.07K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$4.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$11.99K derived: sum of 2 quarters · filed 2026-03-18 | -$37.35K derived: sum of 3 quarters · filed 2026-03-18 | -$335.03K 10-K · filed 2026-03-18 |
| 2024-09-30 | -$7.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$32.95K derived: sum of 2 quarters · filed 2025-11-12 | -$330.63K 10-Q · filed 2025-11-12 | -$658.50K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$25.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$323.04K 10-Q · filed 2025-08-14 | -$650.91K derived: sum of 3 quarters · filed 2025-08-14 | -$981.16K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$297.68K 10-Q · filed 2025-05-15 | -$625.55K derived: sum of 2 quarters · filed 2025-05-15 | -$955.80K derived: sum of 3 quarters · filed 2025-05-15 | -$944.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$327.87K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | -$658.12K derived: sum of 2 quarters · filed 2025-04-09 | -$646.32K derived: sum of 3 quarters · filed 2025-04-09 | -$646.32K 10-K · filed 2025-04-09 |
| 2023-09-30 | -$330.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$318.45K derived: sum of 2 quarters · filed 2024-11-14 | -$318.45K 10-Q · filed 2024-11-14 | -$318.45K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $11.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $11.80K 10-Q · filed 2024-08-14 | $11.80K derived: sum of 3 quarters · filed 2024-08-14 | $11.80K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $0.00 derived: sum of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |